サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1475162

In Vivo CROの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global In Vivo CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 222 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
In Vivo CROの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年04月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In Vivo CRO市場の世界需要は、2023年の50億6,000万米ドルから2032年には約101億9,000万米ドルの市場規模に達すると推定され、調査期間2024～2032年のCAGRは8.09%です。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、In Vivo CROの世界市場における各セグメントを包括的に評価することもできます。In Vivo CRO産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

In Vivo CRO市場レポートのこのセクションは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会とともに、それぞれの製品またはサービスの対象層を特定するのに役立ちます。

動物モデル別

  • げっ歯類ベース（ラットモデル、マウスモデル、その他のげっ歯類モデル）
  • 非げっ歯類ベース

サービス別

  • バイオ分析＆Dmpk試験
  • 毒性試験（GLP毒性試験、非GLP毒性試験）
  • その他

医薬品タイプ別

  • 低分子医薬品
  • 高分子医薬品（細胞・遺伝子治療、RNA治療、その他）

治療領域別

  • がん領域
  • 臨床薬理学
  • 循環器領域
  • 感染症
  • 神経学
  • 消化器・肝臓学
  • 代謝・内分泌
  • 眼科
  • 自己免疫／炎症性疾患
  • その他

用途別

  • 製薬・バイオ製薬企業
  • 医療機器企業
  • 学術・研究機関

地域別分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるIn Vivo CRO市場の現在と将来の需要について、地域別の展望を取り上げます。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 In Vivo CRO-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 In Vivo CROの世界市場分析：動物モデル別

  • 動物モデル別概要
  • 実績データと予測データ
  • 動物モデル別分析
  • げっ歯類ベース（ラットモデル、マウスモデル、その他のげっ歯類モデル）
  • 非齧歯動物モデル

第6章 In Vivo CROの世界市場分析：サービス別

  • サービス別概要
  • 実績データと予測データ
  • サービス別分析
  • バイオ分析＆DMPK試験
  • 毒性試験（GLP毒性試験、非GLP毒性試験）
  • その他サービス

第7章 世界のIn Vivo CRO市場分析：薬剤タイプ別

  • 薬剤タイプ別概要
  • 実績データと予測データ
  • 薬剤タイプ別分析
  • 低分子医薬品
  • 高分子医薬品（細胞・遺伝子治療、RNA治療、その他）

第8章 In Vivo CROの世界市場分析：治療領域別

  • 概要治療領域別
  • 実績データと予測データ
  • 治療領域別分析
  • がん領域
  • 臨床薬理学
  • 循環器領域
  • 感染症学
  • 神経学
  • 消化器・肝臓学
  • 代謝・内分泌
  • 眼科
  • 自己免疫／炎症性疾患
  • その他

第9章 In Vivo CROの世界市場分析：最終用途別

  • 用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 製薬・バイオ医薬品企業
  • 医療機器企業
  • 学術・研究機関

第10章 In Vivo CROの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 In Vivo CRO企業の競合情勢

  • In Vivo CRO市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Biocytogen
  • Charles River Laboratories International Inc.
  • Crown Bioscience
  • Evotec
  • GemPharmatech
  • IQVIA Inc.
  • Icon Plc
  • Labcorp Drug Development
  • Parexel International Corporation
  • PsychoGenics Inc.
  • Taconic Biosciences Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Animal Model (USD MN)
  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Market Sales By Geography (USD MN)
  • Non-Rodent-Based Market Sales By Geography (USD MN)
  • Analysis By Service (USD MN)
  • Bioanalysis & DMPK Studies Market Sales By Geography (USD MN)
  • Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Analysis By Drug Type (USD MN)
  • Small-Molecule Drugs Market Sales By Geography (USD MN)
  • Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Clinical Pharmacology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Gastroenterology & Hepatology Market Sales By Geography (USD MN)
  • Metabolic & Endocrine Market Sales By Geography (USD MN)
  • Ophthalmology Market Sales By Geography (USD MN)
  • Autoimmune / Inflammatory Conditions Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global In Vivo CRO Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vivo CRO Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vivo CRO Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Animal Model
  • Market Attractiveness Analysis By Service
  • Market Attractiveness Analysis By Drug Type
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Animal Model (USD MN)
  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Market Sales By Geography (USD MN)
  • Non-Rodent-Based Market Sales By Geography (USD MN)
  • Global Market Analysis By Service (USD MN)
  • Bioanalysis & DMPK Studies Market Sales By Geography (USD MN)
  • Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Type (USD MN)
  • Small-Molecule Drugs Market Sales By Geography (USD MN)
  • Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Oncology Market Sales By Geography (USD MN)
  • Clinical Pharmacology Market Sales By Geography (USD MN)
  • Cardiology Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Neurology Market Sales By Geography (USD MN)
  • Gastroenterology & Hepatology Market Sales By Geography (USD MN)
  • Metabolic & Endocrine Market Sales By Geography (USD MN)
  • Ophthalmology Market Sales By Geography (USD MN)
  • Autoimmune / Inflammatory Conditions Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical & Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Medical Device Companies Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114389

The global demand for In Vivo CRO Market is presumed to reach the market size of nearly USD 10.19 Billion by 2032 from USD 5.06 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vivo cro. The growth and trends of in vivo cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vivo cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Model

  • Rodent-Based (Rat Models, Mice Models, Other Rodent Models)
  • Non-Rodent-Based

By Service

  • Bioanalysis & Dmpk Studies
  • Toxicity Studies (Glp Toxicology Studies, Non-Glp Toxicology Studies)
  • Other Services

By Drug Type

  • Small-Molecule Drugs
  • Large-Molecule Drugs (Cell & Gene Therapy, Rna Therapy, Other)

By Therapeutic Area

  • Oncology
  • Clinical Pharmacology
  • Cardiology
  • Infectious Diseases
  • Neurology
  • Gastroenterology & Hepatology
  • Metabolic & Endocrine
  • Ophthalmology
  • Autoimmune / Inflammatory Conditions
  • Other

By End-Use

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vivo CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vivo CRO market include Biocytogen, Charles River Laboratories International Inc., Crown Bioscience, Evotec, GemPharmatech, IQVIA Inc., Icon Plc, Labcorp Drug Development, Parexel International Corporation, PsychoGenics Inc., Taconic Biosciences, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. IN VIVO CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Animal Model
    • 3.7.2 Market Attractiveness Analysis By Service
    • 3.7.3 Market Attractiveness Analysis By Drug Type
    • 3.7.4 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL IN VIVO CRO MARKET ANALYSIS BY ANIMAL MODEL

  • 5.1. Overview By Animal Model
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Animal Model
  • 5.4. Rodent-Based (Rat Models, Mice Models, Other Rodent Models) Historic and Forecast Sales By Regions
  • 5.5. Non-Rodent-Based Historic and Forecast Sales By Regions

6. GLOBAL IN VIVO CRO MARKET ANALYSIS BY SERVICE

  • 6.1. Overview By Service
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Service
  • 6.4. Bioanalysis & DMPK Studies Historic and Forecast Sales By Regions
  • 6.5. Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies) Historic and Forecast Sales By Regions
  • 6.6. Other Services Historic and Forecast Sales By Regions

7. GLOBAL IN VIVO CRO MARKET ANALYSIS BY DRUG TYPE

  • 7.1. Overview By Drug Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Drug Type
  • 7.4. Small-Molecule Drugs Historic and Forecast Sales By Regions
  • 7.5. Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other) Historic and Forecast Sales By Regions

8. GLOBAL IN VIVO CRO MARKET ANALYSIS BY THERAPEUTIC AREA

  • 8.1. Overview By Therapeutic Area
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By Therapeutic Area
  • 8.4. Oncology Historic and Forecast Sales By Regions
  • 8.5. Clinical Pharmacology Historic and Forecast Sales By Regions
  • 8.6. Cardiology Historic and Forecast Sales By Regions
  • 8.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 8.8. Neurology Historic and Forecast Sales By Regions
  • 8.9. Gastroenterology & Hepatology Historic and Forecast Sales By Regions
  • 8.10. Metabolic & Endocrine Historic and Forecast Sales By Regions
  • 8.11. Ophthalmology Historic and Forecast Sales By Regions
  • 8.12. Autoimmune / Inflammatory Conditions Historic and Forecast Sales By Regions
  • 8.13. Other Historic and Forecast Sales By Regions

9. GLOBAL IN VIVO CRO MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-use
  • 9.2. Historical and Forecast Data
  • 9.3. Analysis By End-use
  • 9.4. Pharmaceutical & Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 9.5. Medical Device Companies Historic and Forecast Sales By Regions
  • 9.6. Academic & Research Institutes Historic and Forecast Sales By Regions

10. GLOBAL IN VIVO CRO MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE IN VIVO CRO COMPANIES

  • 11.1. In Vivo CRO Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF IN VIVO CRO INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Biocytogen
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Charles River Laboratories International Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Crown Bioscience
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Evotec
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. GemPharmatech
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. IQVIA Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Icon Plc
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Labcorp Drug Development
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Parexel International Corporation
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. PsychoGenics Inc.
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Taconic Biosciences Inc.
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies